Showing results (101-110 of 203) with videos related to
Sort By:
Pageof 21
Vaccine|March 4, 2017
Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trialLisa A Jackson, Sharon E Frey, Hana M El Sahly, et al.Frontiers in Microbiology|January 24, 2019
Streptococcus infantis, Streptococcus mitis, and Streptococcus oralis Strains With Highly Similar cps5 Loci and Antigenic Relatedness to Serotype 5 PneumococciFabiana Pimenta, Robert E Gertz, So Hee Park, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine dosesSanjeev Kumar, Lilin Lai, Madison L Ellis, et al.Cell Reports. Medicine|April 5, 2025
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipientsMengyun Hu, Ana Paula B N Oliveira, Zhuoqing Fang, et al.Nature Immunology|December 17, 2013
Molecular signatures of antibody responses derived from a systems biology study of five human vaccinesShuzhao Li, Nadine Rouphael, Sai Duraisingham, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2024
Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia Among Adults Hospitalized With Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022Wesley H Self, Kelly D Johnson, J Jackson Resser, et al.JAMA|October 8, 2014
Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trialRobert B Belshe, Sharon E Frey, Irene L Graham, et al.Vaccines|July 30, 2020
Alterations in the Human Plasma Lipidome in Response to Tularemia VaccinationKristal M Maner-Smith, Johannes B Goll, Manoj Khadka, et al.The Journal of Clinical Investigation|March 23, 2023
Durability of immune responses to mRNA booster vaccination against COVID-19Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.Vaccine|July 29, 2017
Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical TrialMark J Mulligan, Jack T Stapleton, Wendy A Keitel, et al.Pageof 21